TOXOCARIASIS (TOXOCARA CANIS) - ANVISA Registration 80826840135
Access comprehensive regulatory information for TOXOCARIASIS (TOXOCARA CANIS) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80826840135 and manufactured by R-BIOPHARM AG. The registration is held by SERION BRASIL IMPORTAÇÃO E DISTRIBUIÇÃO DE PRODUTOS DIAGNÓSTICOS LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 4 companies making the same product including NOVATEC IMMUNDIAGNOSTICA GMBH, GOLD STANDARD DIAGNOSTICS FRANKFURT GMBH, and 4 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
80826840135
25351621973201946
14021899000133
Company Information
Dates and Status
Dec 02, 2019
VIGENTE
09/18/2025 19:00:01
TOXOCARIOSE (TOXOCARA CANIS)
NovaLisa® Toxocara canis IgG ELISA
GOLD STANDARD DIAGNOSTICS FRANKFURT GMBH
80464810917
Mar 05, 2025
TOXOCARIOSE (TOXOCARA CANIS)
Anti-Toxocara ELISA (IgG)
EUROIMMUN AG
10338930279
Mar 25, 2022
TOXOCARIOSE (TOXOCARA CANIS)
NovaLisa® Toxocara canis IgG
NOVATEC IMMUNDIAGNOSTICA GMBH
81905510031
Jan 20, 2022
TOXOCARIOSE (TOXOCARA CANIS)
Toxocara canis IgG - ELISA
NOVATEC
80464810504
May 29, 2017

